Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 3 Interventional Results available

Study to Determine if a New Nicotine Replacement Therapy Can Safely Help Smokers to Quit Smoking

ClinicalTrials.gov ID: NCT01296698

Public ClinicalTrials.gov record NCT01296698. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 22, 2026, 9:11 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 26-Week Trial to Measure the Efficacy and Safety of a Novel Nicotine Replacement Therapy in Smokers in a Naturalistic Environment

Study identification

NCT ID
NCT01296698
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 3
Lead sponsor
McNeil Consumer Healthcare Division of McNEIL-PPC, Inc.
Industry
Enrollment
257 participants

Conditions and interventions

Interventions

  • Placebo Drug
  • Nicotine Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Feb 28, 2011
Primary completion
Mar 31, 2011
Completion
May 31, 2011
Last update posted
Apr 22, 2012

2011

United States locations

U.S. sites
19
U.S. states
12
U.S. cities
19
Facility City State ZIP Site status
Avalon Discount Drugs Muscle Shoals Alabama 35661
Coast Compounding Pharmacy Oceanside California 92054
Wynn's Pharmacy, Inc. Griffin Georgia 30224
Stark Pharmacy Overland Park Kansas 64116
Goodrich Pharmacy Anoka Minnesota 55303
Goodrich Pharmacy Elk River Minnesota 55330
Goodrich Pharmacy Saint Francis Minnesota 55070
Cub Pharmacy #1924 Saint Louis Park Minnesota 55426
Medicap Pharmacy Clarksdale Mississippi 38614
Liddy's Health Mart Holly Springs Mississippi 38635
Countryside Pharmacy Savannah Missouri 64485
Phil's Pills Albuquerque New Mexico 87110
Kerr Drug Raleigh North Carolina 27609
Family Prescription Center Bethlehem Pennsylvania 18015
T.B. Bond Pharmacy Hillsboro Texas 76645
Inwood Pharmacy Houston Texas 77070
Louis Morgan Drug #1 Longview Texas 75602
Brick Street Pharmacy Tyler Texas 75701
Montpelier Pharmacy, Inc. Montpelier Virginia 23192

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01296698, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 22, 2012 · Synced Jul 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01296698 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →